Our products are not offered to individuals. Our products are intended for use by qualified personnel, for research and for manufacturing only. Most of our products are marketed through leading distributors in the field of scientific supplies and biochemicals. We do not accept one-time orders less than $500. This does not apply to returning clients. Our products may be ordered in any package size, from 0.1 milligram and up, according to the clients' needs. Mostly, the products are sold from stock, to enable fastest supply times. The products are shipped by a courier, and usually may reach their destination as fast as 48 hours. Most products can be ordered at GMP/API Q7 compliant grade.
Patent policy
Some products
are offered for R&D use in accordance with
-
35 USC 271(e)+A13(1) in the U.S.
-
Section 69.1 of Japanese Patent Law in
Japan
-
Section 11, No. 2 of the German Patent Act
of 1981 in Germany
-
Section 60, Paragraph 5b of the U.K.
Patents Act of 1977 in the U.K.
-
Sections 55.2(1) and 55.2(6) and other
common law exemptions of Canadian patent law
-
Section 68B of the Patents Act of 1953 in
New Zealand together with the amendment of same by the Statutes
Amendment Bill of 2002
-
such related
legislation and/or case law as may be or become applicable in the
aforementioned countries
-
such similar laws and rules as may apply in
various other countries.
Extract from
35 U.S.C. 271 Infringement of patent. - Patent Laws
...
(e)
(1) It shall not be an act of infringement to make, use,
offer to sell, or sell within the United States or import into the United
States a patented invention ... solely for uses
reasonably related to the development and submission of information under a
Federal law which regulates the manufacture, use, or sale of drugs or
veterinary biological products.
...
Explanation: ...the "early working" exception allows
a person to use a patented invention while the relevant patents are in force
only for obtaining regulatory approval to sell an equivalent product after
the patents have expired...
|
|
